DIA begins transition to new executive leadership

Monday, December 10, 2012 09:12 AM

DIA, a neutral, global, nonprofit association that provides knowledge resources across the full spectrum of medical product development, announced that Paul Pomerantz, worldwide executive director of DIA, will be leaving effective March 3, 2013, to assume the position of CEO for the American Society of Anesthesiologists.

In the next three months, Pomerantz will work closely with DIA's board of directors to execute a smooth transition that sustains the momentum the organization has achieved under his leadership.

"Paul has been an extraordinary executive director who will be sorely missed, but together we have built a strong foundation for continued growth," said Dr. Ling Su, president of DIA. "We are committed to continuing the implementation of our strategic plan, which is bringing quality programs and services to our members and stakeholders globally. We thank Paul for his contributions and wish him the best of success in his new position."

Under the leadership of Pomerantz, DIA has achieved rapid global expansion and significantly increased its stakeholder relationships—particularly among global health organizations, regulatory agencies and patient groups—driving its transformation into a world-class, knowledge-driven organization.

"This was a very difficult decision to make," Pomerantz said. "The last three years have been among the most fulfilling of my professional career. I am proud of what we accomplished, and confident that DIA's board of directors, staff and volunteers will continue our progress. My new position provides an exciting challenge to serve the needs of a leading medical association and its patients."

The DIA board of directors will announce plans for the executive director search in January.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs